Approvals/NMPA/Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Approved

生物制品

Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Eli Lilly Nederland BV🇨🇳 National Medical Products Administration

Approval Id: 8c7ASNUUhps
Approval Number: 国药准字SJ20170014
Generic Name: 精蛋白锌重组赖脯胰岛素混合注射液(25R)
Generic Name En: Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)
Trade Name: 优泌乐25
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml:300单位(笔芯)
Reg Date: 2024-07-22
Expired Date: 2029-07-21
Company Name: Eli Lilly Nederland BV
Company Detail Path: /organization/eli-lilly-nederland-bv

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 22, 2024

Approval ID

8c7ASNUUhps

Type

生物制品